{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:01:17Z","timestamp":1780362077769,"version":"3.54.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187397","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T18:40:57Z","timestamp":1513190457000},"page":"e0187397","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-7637","authenticated-orcid":true,"given":"Chan","family":"Beals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Peterfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra","family":"Balanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavrila","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Harabagiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serghei","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Vallee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Dardzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"ref1","unstructured":"Federal Drug Administration. Guidance for Industry Rheumatoid Arthritis: Developing Drug Products for Treatment. FDA website. May 2013. Available at: www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm354468.pdf<\/ext-link>. [Last accessed 16 October 2016]"},{"key":"ref2","first-page":"1385","article-title":"OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system","volume":"30","author":"M Ostergaard","year":"2003","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3861","article-title":"Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI","volume":"14","author":"CG Peterfy","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780370807","article-title":"Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis","volume":"37","author":"K Tamai","year":"1994","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/ard.57.3.152","article-title":"Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging","volume":"57","author":"K Gaffney","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0730-725X(98)00008-3","article-title":"Quantification of synovitis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation","volume":"6","author":"M Ostergaard","year":"1998","journal-title":"Magn Reson Imaging"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.58.6.342","article-title":"Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology","volume":"58","author":"DJ Veale","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/03009742.2011.608375","article-title":"Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology","volume":"41","author":"MB Axelsen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.39469","article-title":"Dynamic contrast-enhanced magnetic resonance imagining using pharmacokinetic modeling: initial experience in early arthritis patients","volume":"68","author":"KI Meijer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar4202","article-title":"Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS","volume":"15","author":"CG Peterfy","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e113937","DOI":"10.1371\/journal.pone.0113937","article-title":"Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients","volume":"9","author":"KD MacIsaac","year":"2014","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S710","DOI":"10.1136\/annrheumdis-2012-eular.1267","article-title":"Single-field of view MRI technique for rheumatoid arthritis clinical trials shortens hand\/wrist imaging time","volume":"71","author":"JC DiCarlo","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref14","unstructured":"Ashton E, Durkin E, Kwok E, Evelhoch J. Conversion from signal intensity to Gd concentration may be unnecessary for perfusion assessment of tumors using DEC-MRI. Proceedings of the 15th Annual Meeting of ISMRM, Berlin, 2007."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmri.21472","article-title":"Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions","volume":"28","author":"E Ashton","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","article-title":"Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols","volume":"10","author":"PS Tofts","year":"1999","journal-title":"J Magn Reson Imaging"},{"key":"ref17","article-title":"Medical Imaging, Principles and Practice","author":"E Ashton","year":"2012"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mrm.21349","article-title":"Pharmacokinetic modeling of dynamic contrast enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-\u03b1 therapy","volume":"58","author":"RJ Hodgson","year":"2007","journal-title":"Magn Reson Med"},{"key":"ref19","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"KY Liang","year":"2000","journal-title":"Indian J Stat"},{"key":"ref20","first-page":"109","article-title":"The ethics of sample size: two-sided testing and one-sided thinking","volume":"54","author":"JA Knottnerus","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ard.2003.018457","article-title":"Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change","volume":"64","author":"K Bruynesteyn","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref22","article-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1987"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.33383","article-title":"Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs","volume":"64","author":"R Fleischmann","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"RN Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/annrheumdis-2012-202696","article-title":"MRI comes of age in RA clinical trials","volume":"72","author":"C Peterfy","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/rheumatology\/kem109","article-title":"Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis","volume":"46","author":"MC Greenwood","year":"2007","journal-title":"Rheumatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2010.146043","article-title":"Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years","volume":"70","author":"MU Rahman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/ard.2003.014043","article-title":"Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up","volume":"63","author":"K Bruynesteyn","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.38083","article-title":"The utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis: Report from the imaging group of the American College of Rheumatology RA clinical trials task force","volume":"65","author":"VK Ranganath","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref30","first-page":"S1612","article-title":"Baseline levels of the inflammatory biomarker C-reactive protein are significantly correlated with magnetic resonance imaging measures of synovitis at baseline and after 26 weeks of treatment with adalimumab in patients with early rheumatoid arthritis","volume":"62","author":"C Peterfy","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref31","first-page":"S152","article-title":"Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and join-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomized, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-SCORE)","volume":"70","author":"C Peterfy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref32","first-page":"S1050","article-title":"Magnetic resonance imaging substudy in a phase 2b dose-ranging study of baricitinib, an oral Janus Kinase 1\/ janus Kinase 2 inhibitor, in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis","volume":"64","author":"C Peterfy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/ard.2010.146068","article-title":"Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial","volume":"70","author":"PG Conaghan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"MC Genovese","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/art.30592","article-title":"Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients","volume":"63","author":"M Ostergaard","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/ard.2008.088245","article-title":"MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)","volume":"68","author":"B Hetland ML Ejbjerg","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","article-title":"Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis","volume":"48","author":"PG Conaghan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1136\/ard.2009.127324","article-title":"Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system","volume":"69","author":"F McQueen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"SB Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/annrheumdis-2012-201611","article-title":"Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial","volume":"72","author":"PG Conaghan","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/35.1.50","article-title":"Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. A study of the effect of intraarticular methylprednisolone on the rate of early synovial enhancement","volume":"35","author":"M Ostergaard","year":"1996","journal-title":"Br J Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/art.10084","article-title":"Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging","volume":"46","author":"RJ Reece","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01375657","article-title":"NMR monitoring of rheumatoid arthritis patients receiving anti-TNFalpha monoclonal antibody therapy","volume":"16","author":"D Kalden-Nemeth","year":"1997","journal-title":"Rheumatol Int"},{"key":"ref44","article-title":"Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial","author":"VK Pokuri","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00280-011-1565-4","article-title":"A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors","volume":"68","author":"AD Ricart","year":"2011","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T19:16:44Z","timestamp":1751138204000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187397"}},"subtitle":[],"editor":[{"given":"Xiaojuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187397","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]}}}